Clinical Trials Directory

Trials / Conditions / Advanced Chronic Liver Disease

Advanced Chronic Liver Disease

13 registered clinical trials studyying Advanced Chronic Liver Disease — 6 currently recruiting.

StatusTrialSponsorPhase
CompletedA Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in
NCT06974565
AstraZenecaPhase 1
CompletedA Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine,
NCT06973005
AstraZenecaPhase 1
RecruitingNatural History of Advanced Chronic Liver Diseases
NCT07042308
Chinese University of Hong Kong—
RecruitingPrediction of Decompensation and HCC Development in Advanced Chronic Liver Disease
NCT06523608
University Hospital Muenster—
RecruitingNon-selective Beta-blocker in Compensated Advanced Chronic Liver Disease
NCT06449339
Chinese University of Hong KongPhase 4
RecruitingLSM and SSM for the Diagnosis of CSPH: a Prospective Cohort Study
NCT06181409
McGill University Health Centre/Research Institute of the McGill University Health Centre—
Active Not RecruitingProgram to Avoid NSAIDs in Patients With Advanced Chronic Liver Disease
NCT07249294
Parc de Salut MarN/A
CompletedAdvanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Un
NCT05602870
University Hospital, MontpellierN/A
RecruitingZinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
NCT06434753
Hospital Universitari Vall d'Hebron Research InstitutePhase 3
Recruiting3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
NCT05475015
Shengjing Hospital—
CompletedREpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study
NCT05663944
Nottingham University Hospitals NHS TrustPhase 2
UnknownNon-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery
NCT04615091
Azienda Ospedaliera Universitaria Integrata Verona—
TerminatedThe INFECIR-2 Albumin Prevention Study
NCT02034279
EASL - CLIF ConsortiumPhase 4